Virtu Financial’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-262,020	Closed	-$411K	–	2445
2022 Q3	$411K	Buy	262,020 +58,357	+29%	+$132K	0.04%	492
2022 Q2	$409K	Buy	+203,663	New	+$352K	0.03%	448
2021 Q2	–	Sell	-113,385	Closed	-$938K	–	2274
2021 Q1	$938K	Sell	113,385 -148,410	-57%	-$1.57M	0.07%	276
2020 Q4	$1.79M	Buy	+261,795	New	+$2.1M	0.19%	125
2019 Q4	$303K	Buy	+89,749	New	+$214K	0.03%	675
2019 Q3	–	Sell	-43,041	Closed	-$115K	–	1971
2019 Q2	$115K	Buy	43,041 +14,224	+49%	+$51.2K	0.01%	1116
2019 Q1	$137K	Sell	28,817 -40,692	-59%	-$107K	0.01%	1081
2018 Q4	$167K	Buy	69,509 +16,202	+30%	+$52.9K	0.01%	1019
2018 Q3	$235K	Buy	+53,307	New	+$296K	0.02%	994
2018 Q2	–	Sell	-31,083	Closed	-$160K	–	2646
2018 Q1	$160K	Buy	+31,083	New	+$221K	0.01%	1445
2017 Q4	–	Sell	-43,348	Closed	-$74K	–	3183
2017 Q3	$74K	Buy	43,348 +29,258	+208%	+$53.7K	﹤0.01%	2148
2017 Q2	$28K	Buy	+14,090	New	+$27.5K	﹤0.01%	371